I am a South Thames renal registrar trainee at ST7 level with a strong interest in genetic-driven diseases, particularly in London's diverse population, where many patients come from ethnic minority backgrounds. To further this interest, I took time out of training for dedicated research and am currently pursuing a PhD on longitudinal cohorts of APOL1-associated nephropathy in the UK, focusing on SGLT2-i usage.

I am working alongside the renal research team to genotype patients for APOL-1 in the APPLE-CKD study to help determine a predictive signature of high risk APOL1 disease. We are also recruiting into the CKD Africa cohort RADAR (Registry for Rare Kidney Diseases) focussing on patients who are likely to have APOL-1 driven nephropathy.

Lastly, I am conducting the DYNAMO study which looks at novel methods of testing renal reserve. Reduced renal reserve is likely to precede early CKD. Using an inverse SGLT2i stress test is suggested as an alternative to time-consuming methods. A high and low risk cohort of APOL1 patients are being included to explore if high risk healthy APOL1 patients may have reduced renal reserve.